RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Summary

The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adjustment Disorder due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson's Disease (PD) or Idiopathic Pulmonary Fibrosis (IPF) as compared to active-placebo.

Timeline

Start

2025-07-30

Primary completion

2026-11

Completion

2026-12

Drugs

Indications